Validation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Teng, Fei ^a   Han, Qiu Cheng ^a   Ding, Guo Shan ^a   Ni, Zhi Jia ^a   Fu, Hong ^a   Guo, Wen Yuan ^a   Shi, Xiao Min ^a   Gao, Xiao Gang ^a   Ma, Jun ^a   Fu, Zhi Ren ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOMA, HEPATOCELLULAR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SURVIVAL RATE; THEORETICAL MODEL; TREATMENT OUTCOME; VALIDATION STUDY;

CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84934916821     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11733     Document Type: Article

References (20)

1. Zhang, Y., Li, J., Cao, L., Xu, W. & Yin, Z. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives. Seminars in oncology 39, 449-460, doi: 10.1053/j.seminoncol.2012.05.012 (2012).
2. Bertino, G. et al. Systemic therapies in hepatocellular carcinoma: present and future. Future Oncol 9, 1533-1548, doi: 10.2217/fon.13.171 (2013).
3. Mazzaferro, V. et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. The New England journal of medicine 334, 693-699, doi: 10.1056/NEJM199603143341104 (1996).
4. Clavien, P. A. et al. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. The lancet oncology 13, e11-22, doi: 10.1016/S1470-2045(11)70175-9 (2012).
5. Yao, F. Y. et al. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 7, 2587-2596, doi: 10.1111/j.1600-6143.2007.01965.x (2007).
6. Yao, F. Y. et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33, 1394-1403, doi: 10.1053/jhep.2001.24563 (2001).
7. Mazzaferro, V. et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. The lancet oncology 10, 35-43, doi: 10.1016/S1470-2045(08)70284-5 (2009).
8. Teng, F. et al. Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation. World journal of gastroenterology : WJG 20, 10900-10907, doi: 10.3748/wjg.v20.i31.10900 (2014).
9. Adam, R. et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). Journal of hepatology 57, 675-688, doi: 10.1016/j.jhep.2012.04.015 (2012).
10. China Liver Transplant Registry. CLTR 2011 Annual Scientific Report. (2012). Available at: http://www.cltr.org/pages/statistics/statistics-report.jsp. (Accessed: 15th December 2014).
11. Kim, W. R. et al. OPTN/SRTR 2011 Annual Data Report: liver. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 13 Suppl 1, 73-102, doi: 10.1111/ajt.12021 (2013).
12. Melloul, E., Lesurtel, M., Carr, B. I. & Clavien, P. A. Developments in liver transplantation for hepatocellular carcinoma. Seminars in oncology 39, 510-521, doi: 10.1053/j.seminoncol.2012.05.008 (2012).
13. Duvoux, C. et al. Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria. Gastroenterology 143, 986-994 e983; quiz e914-985, doi: 10.1053/j.gastro.2012.05.052 (2012).
14. Otto, G. et al. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? Journal of hepatology 59, 279-284, doi: 10.1016/j.jhep.2013.04.006 (2013).
15. Grasso, A. et al. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation 81, 1532-1541, doi: 10.1097/01.tp.0000209641.88912.15 (2006).
16. Shah, S. A. et al. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 81, 1633-1639, doi: 10.1097/01.tp.0000226069.66819.7e (2006).
17. O'Malley, M. E., Takayama, Y. & Sherman, M. Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease. The American journal of gastroenterology 100, 1523-1528, doi: 10.1111/j.1572-0241.2005.41814.x (2005).
18. Toso, C., Mentha, G. & Majno, P. Liver transplantation for hepatocellular carcinoma: five steps to prevent recurrence. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 11, 2031-2035, doi: 10.1111/j.1600-6143.2011.03689.x (2011).
19. Fan, S. T. et al. Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study. Annals of surgery 254, 569-576, doi: 10.1097/SLA.0b013e3182300a1d (2011).
20. Sun, Y. F. et al. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology 57, 1458-1468, doi: 10.1002/hep.26151 (2013).